240 related articles for article (PubMed ID: 37711822)
1. Role of combined clinical-radiomics model based on contrast-enhanced MRI in predicting the malignancy of breast non-mass enhancements without an additional diffusion-weighted imaging sequence.
Li Y; Yang Z; Lv W; Qin Y; Tang C; Yan X; Yin T; Ai T; Xia L
Quant Imaging Med Surg; 2023 Sep; 13(9):5974-5985. PubMed ID: 37711822
[TBL] [Abstract][Full Text] [Related]
2. Contrasts Between Diffusion-Weighted Imaging and Dynamic Contrast-Enhanced MR in Diagnosing Malignancies of Breast Nonmass Enhancement Lesions Based on Morphologic Assessment.
Li Y; Chen J; Yang Z; Fan C; Qin Y; Tang C; Yin T; Ai T; Xia L
J Magn Reson Imaging; 2023 Sep; 58(3):963-974. PubMed ID: 36738118
[TBL] [Abstract][Full Text] [Related]
3. Non-mass enhancement breast lesions: MRI findings and associations with malignancy.
Liu G; Li Y; Chen SL; Chen Q
Ann Transl Med; 2022 Mar; 10(6):357. PubMed ID: 35433999
[TBL] [Abstract][Full Text] [Related]
4. An MRI-Based Radiomics Model for Predicting the Benignity and Malignancy of BI-RADS 4 Breast Lesions.
Zhang R; Wei W; Li R; Li J; Zhou Z; Ma M; Zhao R; Zhao X
Front Oncol; 2021; 11():733260. PubMed ID: 35155178
[TBL] [Abstract][Full Text] [Related]
5. Diffusion-weighted imaging or dynamic contrast-enhanced curve: a retrospective analysis of contrast-enhanced magnetic resonance imaging-based differential diagnoses of benign and malignant breast lesions.
Yang X; Dong M; Li S; Chai R; Zhang Z; Li N; Zhang L
Eur Radiol; 2020 Sep; 30(9):4795-4805. PubMed ID: 32350660
[TBL] [Abstract][Full Text] [Related]
6. Quantitative apparent diffusion coefficient metrics for MRI-only suspicious breast lesions: any added clinical value?
Li X; Wang H; Gao J; Jiang L; Chen M
Quant Imaging Med Surg; 2023 Oct; 13(10):7092-7104. PubMed ID: 37869329
[TBL] [Abstract][Full Text] [Related]
7. Limited role of DWI with apparent diffusion coefficient mapping in breast lesions presenting as non-mass enhancement on dynamic contrast-enhanced MRI.
Avendano D; Marino MA; Leithner D; Thakur S; Bernard-Davila B; Martinez DF; Helbich TH; Morris EA; Jochelson MS; Baltzer PAT; Clauser P; Kapetas P; Pinker K
Breast Cancer Res; 2019 Dec; 21(1):136. PubMed ID: 31801635
[TBL] [Abstract][Full Text] [Related]
8. Diffusion-weighted imaging (b value = 1500 s/mm(2)) is useful to decrease false-positive breast cancer cases due to fibrocystic changes.
Ochi M; Kuroiwa T; Sunami S; Murakami J; Miyahara S; Nagaie T; Oya M; Yabuuchi H; Hatakenaka M
Breast Cancer; 2013 Apr; 20(2):137-44. PubMed ID: 22161277
[TBL] [Abstract][Full Text] [Related]
9. Combined contrast-enhanced magnetic resonance and diffusion-weighted imaging reading adapted to the "Breast Imaging Reporting and Data System" for multiparametric 3-T imaging of breast lesions.
Pinker K; Bickel H; Helbich TH; Gruber S; Dubsky P; Pluschnig U; Rudas M; Bago-Horvath Z; Weber M; Trattnig S; Bogner W
Eur Radiol; 2013 Jul; 23(7):1791-802. PubMed ID: 23504036
[TBL] [Abstract][Full Text] [Related]
10. Multiparametric MRI model with dynamic contrast-enhanced and diffusion-weighted imaging enables breast cancer diagnosis with high accuracy.
Zhang M; Horvat JV; Bernard-Davila B; Marino MA; Leithner D; Ochoa-Albiztegui RE; Helbich TH; Morris EA; Thakur S; Pinker K
J Magn Reson Imaging; 2019 Mar; 49(3):864-874. PubMed ID: 30375702
[TBL] [Abstract][Full Text] [Related]
11. Adding a Model-free Diffusion MRI Marker to BI-RADS Assessment Improves Specificity for Diagnosing Breast Lesions.
Goto M; Le Bihan D; Yoshida M; Sakai K; Yamada K
Radiology; 2019 Jul; 292(1):84-93. PubMed ID: 31112086
[TBL] [Abstract][Full Text] [Related]
12. Diagnostic Usefulness of Combination of Diffusion-weighted Imaging and T2WI, Including Apparent Diffusion Coefficient in Breast Lesions: Assessment of Histologic Grade.
Kim KW; Kuzmiak CM; Kim YJ; Seo JY; Jung HK; Lee MS
Acad Radiol; 2018 May; 25(5):643-652. PubMed ID: 29339079
[TBL] [Abstract][Full Text] [Related]
13. Investigation of Synthetic Relaxometry and Diffusion Measures in the Differentiation of Benign and Malignant Breast Lesions as Compared to BI-RADS.
Gao W; Zhang S; Guo J; Wei X; Li X; Diao Y; Huang W; Yao Y; Shang A; Zhang Y; Yang Q; Chen X
J Magn Reson Imaging; 2021 Apr; 53(4):1118-1127. PubMed ID: 33179809
[TBL] [Abstract][Full Text] [Related]
14. Combining b2500 diffusion-weighted imaging with BI-RADS improves the specificity of breast MRI.
Saccenti L; Mellon CM; Scholer M; Jolibois Z; Stemmer A; Weiland E; de Bazelaire C
Diagn Interv Imaging; 2023 Sep; 104(9):410-418. PubMed ID: 37208291
[TBL] [Abstract][Full Text] [Related]
15. [Value of radiomics models based on MRI diffusion weighted imaging and apparent diffusion coefficient in differentiating benign and malignant thyroid nodules].
Xu HJ; Yang Q; He P; Luo HH; Deng WM; Liu Z; Luo DH
Zhonghua Yi Xue Za Zhi; 2023 Nov; 103(41):3279-3286. PubMed ID: 37926572
[No Abstract] [Full Text] [Related]
16. Differential diagnosis of mammographically and clinically occult breast lesions on diffusion-weighted MRI.
Partridge SC; Demartini WB; Kurland BF; Eby PR; White SW; Lehman CD
J Magn Reson Imaging; 2010 Mar; 31(3):562-70. PubMed ID: 20187198
[TBL] [Abstract][Full Text] [Related]
17. A simplified scoring protocol to improve diagnostic accuracy with the breast imaging reporting and data system in breast magnetic resonance imaging.
Zhong Y; Li M; Zhu J; Zhang B; Liu M; Wang Z; Wang J; Zheng Y; Cheng L; Li X
Quant Imaging Med Surg; 2022 Jul; 12(7):3860-3872. PubMed ID: 35782247
[TBL] [Abstract][Full Text] [Related]
18. The value of noncontrast MRI in evaluating breast imaging reporting and data system category 0 lesions on digital mammograms.
Zhang R; Xu M; Zhou C; Ding X; Lu H; Ge M; Du L; Bu Y
Quant Imaging Med Surg; 2022 Aug; 12(8):4069-4080. PubMed ID: 35919041
[TBL] [Abstract][Full Text] [Related]
19. Diffusion tensor imaging for characterizing tumor microstructure and improving diagnostic performance on breast MRI: a prospective observational study.
Luo J; Hippe DS; Rahbar H; Parsian S; Rendi MH; Partridge SC
Breast Cancer Res; 2019 Sep; 21(1):102. PubMed ID: 31484577
[TBL] [Abstract][Full Text] [Related]
20. Comparison of Dynamic Contrast-Enhanced MRI and Non-Mono-Exponential Model-Based Diffusion-Weighted Imaging for the Prediction of Prognostic Biomarkers and Molecular Subtypes of Breast Cancer Based on Radiomics.
Zhang L; Zhou XX; Liu L; Liu AY; Zhao WJ; Zhang HX; Zhu YM; Kuai ZX
J Magn Reson Imaging; 2023 Nov; 58(5):1590-1602. PubMed ID: 36661350
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
